NCT02505256

Study Into Treatment of Hyperplasia of Mammary Glands

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 5,000 (estimated)
• Sponsor: Shandong University · Academic / Other
• Sex: Female
• Age: 25 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Hyperplasia of Mammary Glands is a complex disease, and there is no consensus or guideline for the treatment of this disease. This study was launched to investigate into the problem that which patients should be diagnosed as hyperplasia of mammary glands and which patients should be treated.

Detailed description

Females who meet the inclusion criteria will receive breast ultrasonography, mammography and pathological examinations by core needle biopsy. All participants will receive a follow-up at an 6-month interval for 2 years. During the follow-up period, whether the symptoms relieve will be evaluated.

Conditions

• Hyperplasia

Interventions

Type	Name	Description
OTHER	No intervention

Timeline

• Start date: 2015-04-01
• Primary completion: 2017-12-01
• Completion: 2018-12-01
• First posted: 2015-07-22
• Last updated: 2015-07-22

Locations

1 site across 1 country: China